Wilson Simon 4

What Happened

• Simon Wilson, EVP and CEO of Markel Insurance, had two transactions reported. On 2026-02-24 he was awarded 868.117 restricted stock units (RSUs) (reported as acquisition A at $0.00). On 2026-02-26 he sold 100 shares in an open-market sale (S) at $2,079.48 per share, generating $207,948 in proceeds.
• The RSU award is compensation (no cash paid) and the sale was an open-market disposition; awards are typically part of long-term incentive pay, while sales can be routine portfolio activity.

Key Details

• Transaction dates and prices:
  • 2026-02-24: Award of 868.117 RSUs (price reported $0.00).
  • 2026-02-26: Open-market sale of 100 shares at $2,079.48 each; total proceeds $207,948.
• Shares owned after transaction: Not specified in this Form 4 filing.
• Footnote (F1): The 868.117 RSUs vest in two tranches — 629.914 RSUs on 2028-12-31 and 238.203 RSUs on 2029-02-24.
• Filing timeliness: Form 4 filed 2026-02-26 for transactions on 2026-02-24 and 2026-02-26; no late-filing indication in this report.
• Transaction codes: A = award/acquisition of RSUs; S = sale (open market).

Context

• RSU awards are a form of deferred compensation and do not require an immediate cash outlay; vested RSUs convert to shares subject to plan rules and withholding.
• The 100-share sale was an open-market disposal — the filing does not state the reason (e.g., diversification, tax planning), and such sales are often routine. There is no indication here of option exercises, 10b5-1 plans, gifts, or tax-withholding transactions tied to this report.